결과 페이지 28 - 부문: 보건의료 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
모든 나라들
- {{country.name}}
- 모든 나라들
- 미국 (1603)
- 아르헨티나 (21)
- 호주 (141)
- 오스트리아 (74)
- 벨기에 (13)
- 브라질 (86)
- 캐나다 (225)
- 칠레 (9)
- 중국 (409)
- 체코 공화국 (1)
- 덴마크 (15)
- 핀란드 (16)
- 프랑스 (67)
- 독일 (1212)
- 그리스 (4)
- 홍콩 (184)
- 헝가리 (2)
- 인도 (228)
- 인도네시아 (30)
- 아일랜드 (2)
- 이스라엘 (29)
- 이탈리아 (16)
- 일본 (201)
- 말레이시아 (25)
- 멕시코 (93)
- 네덜란드 (4)
- 뉴질랜드 (15)
- 노르웨이 (20)
- 폴란드 (22)
- 카타르 (2)
- 러시아 (7)
- 싱가포르 (27)
- 남아프리카 (11)
- 대한민국 (84)
- 스페인 (13)
- 수리남 (8)
- 스웨덴 (126)
- 스위스 (34)
- 대만 (159)
- 태국 (64)
- 칠면조 (13)
- 영국 (100)
모든 거래소
- {{item.name}}
- 모든 거래소
- Amsterdam (4)
- ASX (141)
- Athens (4)
- Brussels (13)
- BSE (112)
- Budapest (2)
- Buenos Aires (21)
- Canadian Sec (122)
- Cboe CA (6)
- Copenhagen (15)
- Dusseldorf (3)
- Frankfurt (1051)
- Hamburg (1)
- Helsinki (16)
- HKSE (184)
- IOB (100)
- Irish (2)
- Istanbul (13)
- Jakarta (30)
- Johannesburg (11)
- KOSDAQ (20)
- KSE (64)
- Kuala Lumpur (25)
- MCE (13)
- MCX (7)
- Mexico (93)
- Milan (16)
- Munich (38)
- NSE (116)
- NYSE (99)
- NYSE American (28)
- NZSE (15)
- Oslo (20)
- OTC Markets EXMKT (143)
- OTC Markets OTCPK (479)
- OTC Markets OTCQB (92)
- OTC Markets OTCQX (37)
- Paris (67)
- Prague (1)
- Qatar (2)
- Riga (1)
- Santiago (9)
- São Paulo (86)
- Sapporo (3)
- Saudi (8)
- SES (27)
- Shanghai (186)
- Shenzhen (223)
- Stockholm (126)
- Stuttgart (41)
- Swiss (34)
- Taipei Exchange (131)
- Taiwan (28)
- Tech Market Large (264)
- Tech Market Middle (138)
- Tech Market Small (323)
- Tel Aviv (29)
- Thailand (64)
- Tokyo (198)
- Toronto (39)
- TSXV (58)
- Vienna (74)
- Warsaw (22)
- XETRA (78)
보건의료 (5416)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Abbott Laboratories ABT.VI | €110.98 121.32 USD |
-0.02
|
€194.17B 212.26B USD | €0.00 0 USD | €110.98 121.32 USD | €111.10 121.45 USD | €194.17B 212.26B USD | 16.13 | €6.88 7.52 USD | ||
| Abbott Laboratories ABL.F | €110.72 121.03 USD |
+0.22
|
€193.99B 212.06B USD | €1.00 1.09 USD | €110.60 120.9 USD | €110.72 121.03 USD | €193.99B 212.06B USD | 16.13 | €6.86 7.5 USD | ||
| Thermo Fisher Scientific Inc. TN8.F | €511.60 559.25 USD |
+0.37
|
€192.21B 210.11B USD | €35.00 38.26 USD | €510.40 557.94 USD | €511.60 559.25 USD | €192.21B 210.11B USD | 34.26 | €14.93 16.32 USD | ||
| Thermo Fisher Scientific Inc. TN8.DE | €511.50 559.14 USD |
+0.1
|
€192.17B 210.07B USD | €41.00 44.82 USD | €509.20 556.62 USD | €512.90 560.67 USD | €192.17B 210.07B USD | 34.28 | €14.92 16.31 USD | ||
| Thermo Fisher Scientific Inc. TMOF.VI | €510.70 558.26 USD |
-0.1
|
€191.87B 209.74B USD | €0.00 0 USD | €510.70 558.26 USD | €514.00 561.87 USD | €191.87B 209.74B USD | 34.09 | €14.98 16.38 USD | ||
| Amgen Inc. AMGN.MX | MX$6,305.00 373.33 USD |
0
|
MX$3.46T 204.81B USD | MX$3.98K 235.61 USD | MX$6,305.00 373.33 USD | MX$6,305.00 373.33 USD | MX$3.46T 204.81B USD | 26.59 | MX$237.07 14.04 USD | ||
| Novo Nordisk A/S NOVA.F | €42.00 45.91 USD |
+1.2
|
€186.63B 204.01B USD | €731.00 799.08 USD | €41.90 45.8 USD | €42.90 46.9 USD | €186.63B 204.01B USD | 13.46 | €3.12 3.41 USD | ||
| Amgen Inc. AMGN34.SA | R$65.70 13.32 USD |
0
|
R$990.82B 200.82B USD | R$0.00 0 USD | R$65.70 13.32 USD | R$65.70 13.32 USD | R$990.82B 200.82B USD | 26.70 | R$2.46 0.5 USD | ||
| Intuitive Surgical, Inc. ISRG.VI | €499.45 545.97 USD |
+0.33
|
€178.44B 195.06B USD | €0.00 0 USD | €499.00 545.47 USD | €499.80 546.35 USD | €178.44B 195.06B USD | 76.60 | €6.52 7.13 USD | ||
| Intuitive Surgical, Inc. IUI1.F | €494.10 540.12 USD |
-0.58
|
€177.84B 194.4B USD | €341.00 372.76 USD | €494.10 540.12 USD | €502.80 549.63 USD | €177.84B 194.4B USD | 75.89 | €6.51 7.12 USD | ||
| Danaher Corporation DHER34.SA | R$44.10 8.94 USD |
0
|
R$891.15B 180.62B USD | R$0.00 0 USD | R$44.10 8.94 USD | R$44.10 8.94 USD | R$891.15B 180.62B USD | 47.41 | R$0.93 0.19 USD | ||
| GSK plc GSK.BA | ARS 18,880.00 22.32 USD |
+1.07
|
ARS 152.48T 180.23B USD | ARS 2.00 0 USD | ARS 0.00 0 USD | ARS 0.00 0 USD | ARS 152.48T 180.23B USD | 14.76 | ARS 1.28K 1.51 USD | ||
| Amgen Inc. AMGN.VI | €296.75 324.39 USD |
+0.37
|
€159.79B 174.68B USD | €1.00 1.09 USD | €296.60 324.22 USD | €297.55 325.26 USD | €159.79B 174.68B USD | 26.54 | €11.18 12.22 USD | ||
| Amgen Inc. AMG.DE | €296.65 324.28 USD |
+0.42
|
€159.74B 174.62B USD | €460.00 502.84 USD | €296.40 324.01 USD | €297.95 325.7 USD | €159.74B 174.62B USD | 26.62 | €11.14 12.18 USD | ||
| Amgen Inc. AMG.F | €296.30 323.9 USD |
-0.24
|
€159.55B 174.41B USD | €70.00 76.52 USD | €296.05 323.62 USD | €296.30 323.9 USD | €159.55B 174.41B USD | 26.59 | €11.14 12.18 USD | ||
| Bristol-Myers Squibb Company BMY.BA | ARS 25,000.00 29.55 USD |
-1.42
|
ARS 146.31T 172.94B USD | ARS 18.00 0.02 USD | ARS 25,000.00 29.55 USD | ARS 25,620.00 30.28 USD | ARS 146.31T 172.94B USD | 5.79 | ARS 4.31K 5.1 USD | ||
| Gilead Sciences, Inc. GILD.MX | MX$2,337.97 138.44 USD |
0
|
MX$2.91T 172.33B USD | MX$2.49K 147.62 USD | MX$2,337.97 138.44 USD | MX$2,337.97 138.44 USD | MX$2.91T 172.33B USD | 19.72 | MX$118.54 7.02 USD | ||
| Gilead Sciences, Inc. GILD34.SA | R$341.94 69.31 USD |
0
|
R$850.18B 172.32B USD | R$0.00 0 USD | R$341.94 69.31 USD | R$341.94 69.31 USD | R$850.18B 172.32B USD | 19.84 | R$17.23 3.49 USD | ||
| EssilorLuxottica Société anonyme ESLOF | $360.92 — |
+1.33
|
$167.12B — | $7.00 — | $355.00 — | $355.00 — | $167.12B — | 60.96 | $5.92 — | ||
| Boston Scientific Corporation BSX.MX | MX$1,861.00 110.19 USD |
0
|
MX$2.76T 163.67B USD | MX$0.00 0 USD | MX$1,861.00 110.19 USD | MX$1,861.00 110.19 USD | MX$2.76T 163.67B USD | 54.35 | MX$34.24 2.03 USD | ||
| Boston Scientific Corporation B1SX34.SA | R$540.68 109.59 USD |
0
|
R$801.53B 162.46B USD | R$0.00 0 USD | R$540.68 109.59 USD | R$540.68 109.59 USD | R$801.53B 162.46B USD | 54.33 | R$9.95 2.02 USD | ||
| Pfizer Inc. PFE.MX | MX$471.70 27.93 USD |
-0.06
|
MX$2.69T 159.04B USD | MX$1.48K 87.34 USD | MX$471.70 27.93 USD | MX$472.00 27.95 USD | MX$2.69T 159.04B USD | 14.93 | MX$31.58 1.87 USD | ||
| Pfizer Inc. PFIZ34.SA | R$34.26 6.94 USD |
-0.29
|
R$779.17B 157.92B USD | R$1.66K 336.86 USD | R$34.26 6.94 USD | R$34.71 7.04 USD | R$779.17B 157.92B USD | 14.89 | R$2.30 0.47 USD | ||
| Pfizer Inc. PFE.SN | $27.75 — |
+6.49
|
$157.78B — | $0.00 — | $27.75 — | $27.75 — | $157.78B — | 16.13 | $1.72 — | ||
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1.00 — | $0.00 — | $0.00 — | $157.63B — | 19.38 | $14.84 — | ||
| EssilorLuxottica Société anonyme ESL.F | €310.20 339.09 USD |
-0.7
|
€143.64B 157.01B USD | €223.00 243.77 USD | €309.70 338.54 USD | €312.90 342.04 USD | €143.64B 157.01B USD | 60.23 | €5.15 5.63 USD | ||
| EssilorLuxottica Société anonyme ESLC.F | €155.00 169.44 USD |
-0.64
|
€143.54B 156.91B USD | €10.00 10.93 USD | €155.00 169.44 USD | €155.00 169.44 USD | €143.54B 156.91B USD | 60.31 | €2.57 2.81 USD | ||
| EssilorLuxottica Société anonyme ESL.DE | €309.80 338.65 USD |
+0.1
|
€143.45B 156.81B USD | €176.00 192.39 USD | €308.30 337.01 USD | €310.80 339.75 USD | €143.45B 156.81B USD | 60.27 | €5.14 5.62 USD | ||
| EssilorLuxottica Société anonyme EI.VI | €309.30 338.11 USD |
-1.59
|
€143.22B 156.56B USD | €0.00 0 USD | €308.50 337.23 USD | €310.20 339.09 USD | €143.22B 156.56B USD | 60.05 | €5.15 5.63 USD | ||
| Gilead Sciences, Inc. 0QYQ.IL | $125.53 — |
-1.93
|
$156.41B — | $654.00 — | $125.50 — | $128.70 — | $156.41B — | 28.85 | $4.35 — | ||
| Danaher Corporation DAP.F | €196.80 215.13 USD |
-0.36
|
€142.58B 155.86B USD | €128.00 139.92 USD | €196.74 215.06 USD | €196.92 215.26 USD | €142.58B 155.86B USD | 46.96 | €4.19 4.58 USD | ||
| Danaher Corporation DHRC.VI | €196.96 215.3 USD |
+0.03
|
€142.35B 155.61B USD | €0.00 0 USD | €196.96 215.3 USD | €197.66 216.07 USD | €142.35B 155.61B USD | 47.00 | €4.19 4.58 USD | ||
| Danaher Corporation DAP.DE | €196.84 215.17 USD |
-0.77
|
€142.12B 155.36B USD | €158.00 172.72 USD | €196.16 214.43 USD | €196.84 215.17 USD | €142.12B 155.36B USD | 46.97 | €4.19 4.58 USD | ||
| Stryker Corporation SYK.MX | MX$6,760.00 400.27 USD |
0
|
MX$2.59T 153.07B USD | MX$0.00 0 USD | MX$6,760.00 400.27 USD | MX$6,760.00 400.27 USD | MX$2.59T 153.07B USD | 48.30 | MX$139.93 8.29 USD | ||
| Stryker Corporation S1YK34.SA | R$98.47 19.96 USD |
0
|
R$754.52B 152.93B USD | R$0.00 0 USD | R$98.47 19.96 USD | R$98.47 19.96 USD | R$754.52B 152.93B USD | 48.50 | R$2.03 0.41 USD | ||
| Medtronic plc MDTC34.SA | R$274.04 55.54 USD |
0
|
R$751.14B 152.24B USD | R$0.00 0 USD | R$274.04 55.54 USD | R$274.04 55.54 USD | R$751.14B 152.24B USD | 27.84 | R$9.84 1.99 USD | ||
| Gilead Sciences, Inc. GILD.VI | €109.88 120.11 USD |
+0.27
|
€137.49B 150.29B USD | €8.00 8.75 USD | €109.48 119.68 USD | €110.50 120.79 USD | €137.49B 150.29B USD | 19.65 | €5.59 6.11 USD | ||
| Gilead Sciences, Inc. GIS.F | €109.36 119.55 USD |
-0.64
|
€135.68B 148.32B USD | €192.00 209.88 USD | €109.36 119.55 USD | €109.58 119.79 USD | €135.68B 148.32B USD | 19.63 | €5.57 6.09 USD | ||
| Gilead Sciences, Inc. GIS.DE | €108.44 118.54 USD |
-1.29
|
€134.97B 147.54B USD | €974.00 1.06K USD | €108.44 118.54 USD | €110.64 120.94 USD | €134.97B 147.54B USD | 19.46 | €5.57 6.09 USD | ||
| Boston Scientific Corporation BSX.DE | €87.80 95.98 USD |
+0.69
|
€130.52B 142.68B USD | €33.00 36.07 USD | €87.20 95.32 USD | €87.80 95.98 USD | €130.52B 142.68B USD | 54.53 | €1.61 1.76 USD | ||
| Boston Scientific Corporation BSXC.VI | €87.80 95.98 USD |
+0.69
|
€130.16B 142.28B USD | €120.00 131.18 USD | €87.40 95.54 USD | €87.80 95.98 USD | €130.16B 142.28B USD | 54.53 | €1.61 1.76 USD | ||
| Boston Scientific Corporation BSX.F | €86.60 94.67 USD |
-0.23
|
€128.38B 140.34B USD | €201.00 219.72 USD | €86.60 94.67 USD | €87.00 95.1 USD | €128.38B 140.34B USD | 53.78 | €1.61 1.76 USD | ||
| Medtronic plc MDTN.MX | MX$1,729.01 102.38 USD |
0
|
MX$2.36T 139.81B USD | MX$0.00 0 USD | MX$1,729.01 102.38 USD | MX$1,729.01 102.38 USD | MX$2.36T 139.81B USD | 25.50 | MX$67.78 4.01 USD | ||
| Pfizer Inc. PFE.VI | €22.29 24.37 USD |
+0.5
|
€126.73B 138.54B USD | €9.00 9.84 USD | €22.23 24.29 USD | €22.29 24.37 USD | €126.73B 138.54B USD | 14.95 | €1.49 1.63 USD | ||
| Gilead Sciences, Inc. GILD.SN | $110.29 — |
-0.13
|
$136.83B — | $0.00 — | $110.29 — | $110.29 — | $136.83B — | 17.07 | $6.46 — | ||
| Pfizer Inc. PFEB.F | €6.95 7.6 USD |
0
|
€124.75B 136.37B USD | €50.00 54.66 USD | €6.95 7.6 USD | €6.95 7.6 USD | €124.75B 136.37B USD | 13.90 | €0.50 0.55 USD | ||
| HCA Healthcare, Inc. HCA.MX | MX$9,455.00 559.85 USD |
0
|
MX$2.30T 136.33B USD | MX$727.00 43.05 USD | MX$9,455.00 559.85 USD | MX$9,455.00 559.85 USD | MX$2.30T 136.33B USD | 19.92 | MX$474.64 28.1 USD | ||
| STRYKER CORP. R SYK.DE | €322.60 352.65 USD |
+1.77
|
€123.27B 134.75B USD | €70.00 76.52 USD | €320.50 350.35 USD | €322.90 352.97 USD | €123.27B 134.75B USD | 49.17 | €6.56 7.17 USD | ||
| Stryker Corporation SYK.VI | €321.10 351.01 USD |
0
|
€122.92B 134.37B USD | €0.00 0 USD | €321.00 350.9 USD | €321.20 351.11 USD | €122.92B 134.37B USD | 48.79 | €6.58 7.19 USD | ||
| Stryker Corporation SYK.F | €319.70 349.48 USD |
-0.59
|
€122.78B 134.21B USD | €36.00 39.35 USD | €319.70 349.48 USD | €322.50 352.54 USD | €122.78B 134.21B USD | 48.73 | €6.56 7.17 USD | ||
| Sanofi SNYN.MX | MX$927.00 54.89 USD |
0
|
MX$2.26T 133.89B USD | MX$8.00 0.47 USD | MX$927.00 54.89 USD | MX$927.00 54.89 USD | MX$2.26T 133.89B USD | 16.60 | MX$55.81 3.3 USD | ||
| HCA Healthcare, Inc. H1CA34.SA | R$136.17 27.6 USD |
0
|
R$659.15B 133.6B USD | R$0.00 0 USD | R$136.17 27.6 USD | R$136.17 27.6 USD | R$659.15B 133.6B USD | 19.76 | R$6.89 1.4 USD | ||
| Medtronic plc MDT.VI | €90.80 99.26 USD |
+1.44
|
€116.41B 127.25B USD | €0.00 0 USD | €90.75 99.2 USD | €91.06 99.54 USD | €116.41B 127.25B USD | 28.46 | €3.19 3.49 USD | ||
| Medtronic plc 2M6.F | €90.52 98.95 USD |
+1.7
|
€116.05B 126.86B USD | €436.00 476.61 USD | €90.00 98.38 USD | €91.08 99.56 USD | €116.05B 126.86B USD | 28.46 | €3.18 3.48 USD | ||
| Medtronic plc 2M6.DE | €90.46 98.89 USD |
+1.23
|
€115.97B 126.77B USD | €1.72K 1.87K USD | €90.45 98.87 USD | €91.23 99.73 USD | €115.97B 126.77B USD | 28.44 | €3.18 3.48 USD | ||
| Vertex Pharmaceuticals Incorporated VRTX.MX | MX$8,020.00 474.88 USD |
0
|
MX$2.08T 123.44B USD | MX$0.00 0 USD | MX$8,020.00 474.88 USD | MX$8,020.00 474.88 USD | MX$2.08T 123.44B USD | 30.76 | MX$260.65 15.43 USD | ||
| Novo Nordisk A/S NVON.MX | MX$900.00 53.29 USD |
0
|
MX$2.08T 122.9B USD | MX$62.00 3.67 USD | MX$900.00 53.29 USD | MX$900.00 53.29 USD | MX$2.08T 122.9B USD | 14.49 | MX$62.09 3.68 USD | ||
| McKesson Corporation M1CK34.SA | R$1,180.00 239.17 USD |
-1.1
|
R$587.11B 119B USD | R$30.00 6.08 USD | R$1,180.00 239.17 USD | R$1,180.00 239.17 USD | R$587.11B 119B USD | 27.68 | R$42.62 8.64 USD | ||
| Vertex Pharmaceuticals Incorporated VRTX34.SA | R$572.79 116.1 USD |
-0.92
|
R$586.37B 118.85B USD | R$8.00 1.62 USD | R$572.79 116.1 USD | R$572.79 116.1 USD | R$586.37B 118.85B USD | 30.21 | R$18.96 3.84 USD | ||
| Sanofi SNW2.F | €43.00 47 USD |
0
|
€105.23B 115.03B USD | €20.00 21.86 USD | €43.00 47 USD | €43.00 47 USD | €105.23B 115.03B USD | 16.41 | €2.62 2.86 USD | ||
| Sanofi SNW.F | €85.90 93.9 USD |
0
|
€104.88B 114.64B USD | €491.00 536.73 USD | €85.53 93.5 USD | €86.66 94.73 USD | €104.88B 114.64B USD | 16.39 | €5.24 5.73 USD | ||
| Sanofi SANO.VI | €86.10 94.12 USD |
-0.14
|
€104.62B 114.36B USD | €30.00 32.79 USD | €85.76 93.75 USD | €86.21 94.24 USD | €104.62B 114.36B USD | 16.43 | €5.24 5.73 USD | ||
| HCA Healthcare, Inc. 2BH.F | €441.20 482.29 USD |
+0.34
|
€103.85B 113.52B USD | €50.00 54.66 USD | €441.20 482.29 USD | €442.30 483.49 USD | €103.85B 113.52B USD | 19.79 | €22.29 24.37 USD | ||
| Bristol-Myers Squibb Company BMYB34.SA | R$264.45 53.6 USD |
0
|
R$543.75B 110.21B USD | R$0.00 0 USD | R$264.45 53.6 USD | R$264.45 53.6 USD | R$543.75B 110.21B USD | 16.69 | R$15.84 3.21 USD | ||
| CVS Health Corporation CVSH34.SA | R$42.67 8.65 USD |
-0.05
|
R$541.67B 109.79B USD | R$2.00 0.41 USD | R$42.67 8.65 USD | R$42.67 8.65 USD | R$541.67B 109.79B USD | 213.34 | R$0.20 0.04 USD | ||
| Bristol-Myers Squibb Company BMY.MX | MX$903.00 53.47 USD |
0
|
MX$1.84T 108.85B USD | MX$0.00 0 USD | MX$903.00 53.47 USD | MX$903.00 53.47 USD | MX$1.84T 108.85B USD | 16.58 | MX$54.45 3.22 USD | ||
| CVS Health Corporation CVS.MX | MX$1,437.30 85.11 USD |
0
|
MX$1.82T 108.04B USD | MX$0.00 0 USD | MX$1,437.30 85.11 USD | MX$1,437.30 85.11 USD | MX$1.82T 108.04B USD | 204.16 | MX$7.04 0.42 USD | ||
| GSK plc GSKN.MX | MX$864.00 51.16 USD |
0
|
MX$1.77T 104.96B USD | MX$0.00 0 USD | MX$864.00 51.16 USD | MX$864.00 51.16 USD | MX$1.77T 104.96B USD | 13.36 | MX$64.63 3.83 USD | ||
| GSK plc G1SK34.SA | R$51.20 10.38 USD |
-0.49
|
R$516.87B 104.76B USD | R$14.00 2.84 USD | R$51.20 10.38 USD | R$51.25 10.39 USD | R$516.87B 104.76B USD | 13.61 | R$3.76 0.76 USD | ||
| Vertex Pharmaceuticals Incorporated VRTX.VI | €372.40 407.08 USD |
-0.09
|
€95.77B 104.69B USD | €0.00 0 USD | €372.00 406.65 USD | €372.70 407.41 USD | €95.77B 104.69B USD | 30.27 | €12.30 13.45 USD | ||
| Vertex Pharmaceuticals Incorporated VX1.F | €372.45 407.14 USD |
+0.34
|
€95.41B 104.29B USD | €80.00 87.45 USD | €372.45 407.14 USD | €372.45 407.14 USD | €95.41B 104.29B USD | 30.40 | €12.25 13.39 USD | ||
| Vertex Pharmaceuticals Incorporated VX1.DE | €370.55 405.06 USD |
+0.04
|
€95.32B 104.2B USD | €549.00 600.13 USD | €370.55 405.06 USD | €373.00 407.74 USD | €95.32B 104.2B USD | 30.22 | €12.26 13.4 USD | ||
| CVS Health Corporation CVS.SN | $74.24 — |
0
|
$104.02B — | $0.00 — | $74.24 — | $74.24 — | $104.02B — | 195.36 | $0.38 — | ||
| McKesson Corporation MCK.F | €759.60 830.35 USD |
-1.09
|
€94.64B 103.45B USD | €71.00 77.61 USD | €757.40 827.94 USD | €759.60 830.35 USD | €94.64B 103.45B USD | 27.55 | €27.57 30.14 USD | ||
| CVS Health Corporation CVS.DE | €69.71 76.2 USD |
+1.18
|
€88.49B 96.73B USD | €106.00 115.87 USD | €69.71 76.2 USD | €69.71 76.2 USD | €88.49B 96.73B USD | 211.24 | €0.33 0.36 USD | ||
| CVS Health Corporation CVS.VI | €69.10 75.54 USD |
+0.29
|
€87.72B 95.89B USD | €0.00 0 USD | €69.07 75.5 USD | €69.21 75.66 USD | €87.72B 95.89B USD | 209.39 | €0.33 0.36 USD | ||
| CVS Health Corporation CVS.F | €68.82 75.23 USD |
-0.42
|
€87.36B 95.5B USD | €150.00 163.97 USD | €68.82 75.23 USD | €68.82 75.23 USD | €87.36B 95.5B USD | 215.06 | €0.32 0.35 USD | ||
| Bristol-Myers Squibb Company BMYS.VI | €42.62 46.59 USD |
+0.48
|
€86.79B 94.87B USD | €0.00 0 USD | €42.57 46.53 USD | €42.67 46.64 USD | €86.79B 94.87B USD | 16.58 | €2.57 2.81 USD | ||
| Bristol-Myers Squibb Company BRM.DE | €42.46 46.41 USD |
-0.12
|
€86.50B 94.55B USD | €315.00 344.34 USD | €42.46 46.41 USD | €42.76 46.74 USD | €86.50B 94.55B USD | 16.58 | €2.56 2.8 USD | ||
| Chugai Pharmaceutical CHGCF | $54.24 — |
-2.02
|
$94.45B — | $500.00 — | $52.05 — | $52.18 — | $94.45B — | 35.45 | $1.53 — | ||
| GSK GLAXF | $23.38 — |
-2.54
|
$94.41B — | $120.00 — | $23.00 — | $23.00 — | $94.41B — | 13.35 | $1.75 — | ||
| Bristol-Myers Squibb Company BRM.F | €42.26 46.19 USD |
-1.31
|
€86.02B 94.03B USD | €295.00 322.47 USD | €42.22 46.15 USD | €42.84 46.82 USD | €86.02B 94.03B USD | 16.50 | €2.56 2.8 USD | ||
| Regeneron Pharmaceuticals, Inc. REGN34.SA | R$70.21 14.23 USD |
-0.58
|
R$445.92B 90.38B USD | R$10.00 2.03 USD | R$70.21 14.23 USD | R$70.21 14.23 USD | R$445.92B 90.38B USD | 18.92 | R$3.71 0.75 USD | ||
| Regeneron Pharmaceuticals, Inc. REGN.MX | MX$14,275.73 845.3 USD |
0
|
MX$1.52T 89.95B USD | MX$0.00 0 USD | MX$14,275.73 845.3 USD | MX$14,275.73 845.3 USD | MX$1.52T 89.95B USD | 18.65 | MX$765.18 45.31 USD | ||
| Cardinal Health, Inc. CAH.BA | ARS 108,075.00 127.75 USD |
-1.03
|
ARS 73.13T 86.44B USD | ARS 3.00 0 USD | ARS 104,250.00 123.23 USD | ARS 110,000.00 130.02 USD | ARS 73.13T 86.44B USD | 3.73 | ARS 28.90K 34.16 USD | ||
| Chugai Pharmaceutical Co., Ltd. CUP.F | €45.70 49.96 USD |
+0.13
|
€76.01B 83.09B USD | €345.00 377.13 USD | €45.66 49.91 USD | €46.60 50.94 USD | €76.01B 83.09B USD | 34.62 | €1.32 1.44 USD | ||
| The Cigna Group CI.MX | MX$5,020.00 297.25 USD |
0
|
MX$1.34T 79.4B USD | MX$0.00 0 USD | MX$5,020.00 297.25 USD | MX$5,020.00 297.25 USD | MX$1.34T 79.4B USD | 12.10 | MX$414.65 24.55 USD | ||
| The Cigna Group C1IC34.SA | R$365.80 74.14 USD |
0
|
R$390.86B 79.22B USD | R$0.00 0 USD | R$365.80 74.14 USD | R$365.80 74.14 USD | R$390.86B 79.22B USD | 12.14 | R$30.11 6.1 USD | ||
| Regeneron Pharmaceuticals, Inc. REGN.VI | €679.40 742.68 USD |
+0.56
|
€72.03B 78.74B USD | €0.00 0 USD | €677.60 740.71 USD | €679.40 742.68 USD | €72.03B 78.74B USD | 18.83 | €36.08 39.44 USD | ||
| Cigna Group, The R CGN.DE | €240.10 262.46 USD |
0
|
€71.55B 78.21B USD | €40.00 43.73 USD | €240.10 262.46 USD | €240.10 262.46 USD | €71.55B 78.21B USD | 12.33 | €19.47 21.28 USD | ||
| Elevance Health, Inc. A58.F | €291.50 318.65 USD |
+0.07
|
€66.30B 72.48B USD | €23.00 25.14 USD | €291.30 318.43 USD | €291.30 318.43 USD | €66.30B 72.48B USD | 13.78 | €21.15 23.12 USD | ||
| The Cigna Group CIGN.VI | €241.55 264.05 USD |
+0.58
|
€64.52B 70.53B USD | €0.00 0 USD | €240.75 263.17 USD | €241.55 264.05 USD | €64.52B 70.53B USD | 12.37 | €19.52 21.34 USD | ||
| The Cigna Group CGN.F | €239.25 261.53 USD |
+0.17
|
€63.91B 69.86B USD | €14.00 15.3 USD | €239.25 261.53 USD | €239.25 261.53 USD | €63.91B 69.86B USD | 12.28 | €19.47 21.28 USD | ||
| Cencora, Inc. ABG.SG | €318.35 348 USD |
-0.83
|
€61.76B 67.51B USD | €0.00 0 USD | €318.35 348 USD | €318.35 348 USD | €61.76B 67.51B USD | 46.33 | €6.87 7.51 USD | ||
| IDEXX Laboratories, Inc. IDXX.MX | MX$14,130.00 836.67 USD |
0
|
MX$1.13T 66.81B USD | MX$33.00 1.95 USD | MX$14,130.00 836.67 USD | MX$14,130.00 836.67 USD | MX$1.13T 66.81B USD | 60.97 | MX$231.73 13.72 USD | ||
| Cencora, Inc. ABG.F | €315.00 344.34 USD |
+0.1
|
€61.11B 66.8B USD | €10.00 10.93 USD | €315.00 344.34 USD | €315.00 344.34 USD | €61.11B 66.8B USD | 45.91 | €6.86 7.5 USD | ||
| IDEXX Laboratories, Inc. I1DX34.SA | R$813.60 164.9 USD |
0
|
R$324.84B 65.84B USD | R$0.00 0 USD | R$813.60 164.9 USD | R$813.60 164.9 USD | R$324.84B 65.84B USD | 60.62 | R$13.42 2.72 USD | ||
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | R$117.92 23.9 USD |
0
|
R$311.58B 63.15B USD | R$0.00 0 USD | R$117.92 23.9 USD | R$117.92 23.9 USD | R$311.58B 63.15B USD | 1474.00 | R$0.08 0.02 USD | ||
| argenx SE A1RG34.SA | R$200.20 40.58 USD |
0
|
R$310.18B 62.87B USD | R$0.00 0 USD | R$200.20 40.58 USD | R$200.20 40.58 USD | R$310.18B 62.87B USD | 40.20 | R$4.98 1.01 USD | ||
| Zoetis Inc. ZTS.MX | MX$2,347.25 138.99 USD |
0
|
MX$1.04T 61.79B USD | MX$18.00 1.07 USD | MX$2,347.25 138.99 USD | MX$2,347.25 138.99 USD | MX$1.04T 61.79B USD | 21.55 | MX$108.91 6.45 USD | ||
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
|||||||||||